Back to Journals » Cancer Management and Research » Volume 12

High Systemic Immune-Inflammation Index Predicts Poor Survival in Patients with Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Receiving Adjuvant Trastuzumab

Total article views   HTML views PDF downloads Totals
7,247 Dovepress* 6,795+ 1,007 7,802
PubMed Central* 452 214 666
Totals 7,247 1,221 8,468
*Since 21 January 2020

View citations on PubMed Central and Google Scholar